Skip to main content
Back to News
OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...
Funding
1 min read
US

OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as...

The AMW Read

The $12B valuation exceeds the cross.§D threshold and establishes OpenEvidence as a top-tier vertical leader, validating the 'Bio-platform bull' debate frame via massive scale.
NoveltySignificance
Healthcare & Bio · Player MapCapital Cycles

OpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as the primary AI infrastructure for U.S. healthcare. With 40 percent of domestic physicians already using the tool to manage 100 million patient consultations, the platform effectively solves the critical medical information overload crisis. By utilizing a conductor AI to route queries to specialized sub-specialty models, it achieves clinical accuracy that general models cannot match. This milestone signals a systemic shift toward specialized medical superintelligence as an essential daily utility for global patient safety. 🩺🚀

#OpenEvidence #HealthTech #GenerativeAI #MedicalAI #StartupFunding

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1w agoIambic raises $150 million in IPO, bringing AI drug discovery to public marketsIambic
  2. 2w agoIsomorphic Labs explores funding at a valuation of at least $40 billionIsomorphic Labs
  3. 1mo agoPotential Sciences is negotiating a £500 million round with the UK's Sovereign AI Investment Fund.Potential Sciences
  4. 1mo agoLevel Five, a game developer, has issued a public apology after facing criticism for what it called...Level Five
  5. 9mo agoOpenEvidence has secured 250 million dollars at a 12 billion dollar valuation, cementing its role as... · THIS ARTICLE

Related News

More news from OpenEvidence

Stay updated with the latest news and announcements from OpenEvidence.

View all OpenEvidence news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard